Generalized Rhythmic Delta Activity Frontally Predominant Differentiates Dementia with Lewy Bodies From Alzheimer's Disease and Parkinson's Disease Dementia: A Conventional Electroencephalography Visual Analysis
Clinical EEG and Neuroscience · 2022-09 · 53 (5) · 426-434
DOI: 10.1177/1550059421997147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical EEG and Neuroscience, online erschienen am 12.04.2021. Verfasst von Lucia Zinno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, 18630Azienda Ospedaliero-Universitaria of Parma, Parma, Emilia-Romagna, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Dementia, Lewy Body Disease, Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Introduction
An easily accessible and inexpensive neurophysiological technique such as conventional electroencephalography may provide an accurate and generally applicable biomarker capable of differentiating dementia with Lewy bodies (DLB) from Alzheimer’s disease (AD) and Parkinson’s disease-associated dementia (PDD).
Method
We carried out a retrospective visual analysis of resting-state electroencephalography (EEG) recording of 22 patients with a clinical diagnosis of 19 probable and 3 possible DLB, 22 patients with probable AD and 21 with PDD, matched for age, duration, and severity of cognitive impairment.
Results
By using the grand total EEG scoring method, the total score and generalized rhythmic delta activity frontally predominant (GRDAfp) alone or, even better, coupled with a slowing of frequency of background activity (FBA) and its reduced reactivity differentiated DLB from AD at an individual level with an high accuracy similar to that obtained with quantitative EEG (qEEG). GRDAfp alone could also differentiate DLB from PDD with a similar level of diagnostic accuracy. AD differed from PDD only for a slowing of FBA. The duration and severity of cognitive impairment did not differ between DLB patients with and without GRDAfp, indicating that this abnormal EEG pattern should not be regarded as a disease progression marker.
Conclusions
The findings of this investigation revalorize the role of conventional EEG in the diagnostic workup of degenerative dementias suggesting the potential inclusion of GRDAfp alone or better coupled with the slowing of FBA and its reduced reactivity, in the list of supportive diagnostic biomarkers of DLB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Unit, 18630Azienda Ospedaliero-Universitaria of Parma, Parma, Emilia-Romagna, Italy.
- Center for Cognitive Disorders, AUSL of Parma, Parma, Emilia-Romagna, Italy.
- 478519University of Parma, Parma, Emilia-Romagna, Italy.
Zitieren
APA
Zinno, L., Negrotti, A., Falzoi, C., Messa, G., Goldoni, M., & Calzetti, S. (2022). Generalized Rhythmic Delta Activity Frontally Predominant Differentiates Dementia with Lewy Bodies From Alzheimer's Disease and Parkinson's Disease Dementia: A Conventional Electroencephalography Visual Analysis. Clinical EEG and Neuroscience, 53(5), 426-434. https://doi.org/10.1177/1550059421997147
Vancouver
Zinno L, Negrotti A, Falzoi C, Messa G, Goldoni M, Calzetti S. Generalized Rhythmic Delta Activity Frontally Predominant Differentiates Dementia with Lewy Bodies From Alzheimer's Disease and Parkinson's Disease Dementia: A Conventional Electroencephalography Visual Analysis. Clinical EEG and Neuroscience. 2022;53(5):426-434. doi:10.1177/1550059421997147
BibTeX
@article{Zinno2022,
author = {Zinno, Lucia and Negrotti, Anna and Falzoi, Chiara and Messa, Giovanni and Goldoni, Matteo and Calzetti, Stefano},
title = {Generalized Rhythmic Delta Activity Frontally Predominant Differentiates Dementia with Lewy Bodies From Alzheimer's Disease and Parkinson's Disease Dementia: A Conventional Electroencephalography Visual Analysis},
journal = {Clinical EEG and Neuroscience},
year = {2022},
volume = {53},
number = {5},
pages = {426--434},
doi = {10.1177/1550059421997147}
}
EUVIMED